FJL · Class II · 21 CFR 876.1500

FDA Product Code FJL: Resectoscope

Leading manufacturers include KARL STORZ Endoscopy-America, Inc., Corinth Medtech, Inc. and Karl Storz SE & CO. KG.

24
Total
24
Cleared
121d
Avg days
1976
Since
Declining activity - 0 submissions in the last 2 years vs 3 in the prior period

FDA 510(k) Cleared Resectoscope Devices (Product Code FJL)

24 devices
1–24 of 24
Cleared May 07, 2024
KARL STORZ Monopolar Resectoscopes with HF Cable
K232486
Karl Storz SE & CO. KG
Gastroenterology & Urology · 265d
Cleared Mar 17, 2023
KARL STORZ Bipolar Resectoscopes with HF Cable
K221893
KARL STORZ Endoscopy-America, Inc.
Gastroenterology & Urology · 261d
Cleared Feb 24, 2023
Veloxion System
K230205
Corinth Medtech, Inc.
Gastroenterology & Urology · 30d
Cleared Jun 13, 2019
Veloxion Controller Kit, Veloxion Fluid Control Set, Veloxion Resectoscope, Veloxion Video Control Unit, Veloxion Roll Stand, Waste Management Tubing, Tissue Catch, Waste Management Bags
K191341
Corinth Medtech, Inc.
Gastroenterology & Urology · 24d
Cleared Mar 15, 2019
Veloxion Controller Kit, Veloxion Fluid Control Kit, Veloxion Resectoscope, Veloxion Video Control Unit, Veloxion Roll Stand, Waste Management Tubing, Tissue Catch
K190099
Corinth Medtech, Inc.
Gastroenterology & Urology · 52d
Cleared May 01, 1996
KARL STORZ URETER RESECTOSCOPE
K960757
KARL STORZ Endoscopy-America, Inc.
Gastroenterology & Urology · 68d
Cleared Nov 22, 1995
RESECTOSCOPES
K954050
KARL STORZ Endoscopy-America, Inc.
Gastroenterology & Urology · 85d
Cleared Jul 20, 1995
KARL STORZ INSULATED GROOVED, SKIKED, ABLATOR, FIXED BARREL WITH GROOVES, COAGULATING LOOP, DEPTH-LIMITING LOOP ELECTROS
K952574
KARL STORZ Endoscopy-America, Inc.
Gastroenterology & Urology · 45d
Cleared Feb 09, 1994
KARL STORZ CUTTING LOOP ELECTRODES MODIFICATION
K934647
KARL STORZ Endoscopy-America, Inc.
Gastroenterology & Urology · 133d

About Product Code FJL - Regulatory Context

510(k) Submission Activity

24 total 510(k) submissions under product code FJL since 1976, with 24 receiving FDA clearance (average review time: 121 days).

Submission volume has declined in recent years - 0 submissions in the last 24 months compared to 3 in the prior period.